TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/18/24 20:49 | 3/18/24 | ACLX | Arcellx, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gilson Michelle | CA | O | CFO | S | -473 | 69.34 | 0 | -7 | -42 | 9 | D | ||||||||||||||
1/8/24 16:04 | 1/4/24 | ACLX | Arcellx, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gilson Michelle | MD | O | CFO | S | -471 | 55.27 | 0 | -9 | -34 | 16 | D | ||||||||||||||
1/4/24 19:31 | 1/3/23 | ACLX | Arcellx, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gilson Michelle | MD | O | CFO | M.d | 0 | 0.00 | 0 | 15 | 162 | 25 | D | ||||||||||||||
5/25/23 20:21 | 5/23/23 | ACLX | Arcellx, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gilson Michelle | MD | O | CFO | M.d | 0 | 0.00 | 0 | 22 | 9 | D | |||||||||||||||
5/25/23 20:21 | 5/24/23 | ACLX | Arcellx, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gilson Michelle | MD | O | CFO | S.dm | -626 | 42.58 | 0 | -15 | -61 | 9 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |